Editorial Board

Cochrane's Editorial Board is responsible for supporting our Editor in Chief and overseeing the production of Cochrane reviews and other Cochrane Library content.

Main roles of the Editorial Board

• Development of editorial, publishing, and content strategies with the Editor in Chief;
• Supporting the Editor in Chief in the implementation of changes to improve consistency in the quality and timeliness of Cochrane review preparation and publication;
• Supporting the Editor in Chief in the development, implementation, and audit of editorial policies and practices;
• Monitoring the performance of the Cochrane Library;
• Working closely with the Editor in Chief to develop and oversee implementation of future strategy for the Cochrane Library.

Editorial Board membership

The Editorial Board includes the past Network Senior Editors and other content and methods evidence synthesis leaders, including representatives from low- and middle-income countries, the Cochrane Patient and Public Network, and the Cochrane Early Career Professional Group.

The Editorial Board is chaired by the Editor in Chief. Members of the Editorial Board are appointed for a renewable fixed term.

View Editorial Board members on the Cochrane Library

View the Editorial Board's Conflict of Interest declarations

Conflict of Interest Panel

Main roles of the Research Integrity Editors and Conflict of Interest Panel

The Research Integrity Editors and the Conflict of Interest Panel arbitrate on potential breaches of the Cochrane Conflict of Interest Policy for Cochrane Library Content and provide general guidance on how the policy should be applied. For more information, see the Conflict of Interest Panel's Terms of Reference and Responsibilities and Qualifications.

Research Integrity Editors

Senior Research Integrity Editor: Lisa Bero

Research Integrity Editor: Jivitesh Newoor

Conflict of Interest Panel membership

• Vanessa Jordan (Chair)
• Lisa Cosgrove
• Iván D. Flórez
• Quinn Grundy

Patient and Public Network Executive

Our Patient and Public Network Executive provides leadership for the growing, international community of patients and the public who help produce and share Cochrane evidence.

Find out more about the Patient and Public Network Executive and it’s membership.  

Methods Executive  

Main roles of the Methods Executive

The Methods Executive provides a leadership forum within Cochrane and ensures that all key methodological roles are able to meet and liaise. It provides advice an advisory role to the Editor in Chief and other Cochrane governance committees, as well as supporting the Methods Groups and wider methods community in Cochrane.

For more information, see the Methods Executive's Terms of Reference.

Methods Executive membership

• Michael Brown (Editor of Cochrane Evidence Synthesis and Methods)
• Chantelle Garritty (Rapid Reviews Methods Group )
• Tianjing Li (Comparing Multiple Interventions Methods Group, Handbook Editor, leaving end of 2025) (Co-Chair)
• Evan Mayo-Wilson (Adverse Effects Methods Group)
• Carl Moons (Prognosis Methods Group, leaving end of 2025)
• Jane Noyes (Qualitative and Implementation Methods Group, Editorial Board, leaving end of 2025)
• Matt Page (Bias Methods Group, Handbook Editor) (Co-Chair)
• Areti Angeliki Veroniki (Statistics Methods Group) (Co-Chair)
• Incoming October 2025: Candyce Hamel (Rapid Reviews and, AI Methods Group, Editorial Board)
• Incoming October 2025: Kylie Hunter (Prospective MA Methods Group)

There are four ex-officio roles: Methods Implementation Editor (Jo-Ana Chase), Methods Support Unit Manager (Rachel Richardson), Head of Editorial Policy and Research Integrity (Ella Flemyng) and Head of Engagement, Learning and Support (Rob Beswick).